NovaBay Pharmaceuticals, Inc. Press Releases

NBY 
$0.7745
*  
0.0245
3.27%
Get NBY Alerts
*Delayed - data as of Sep. 19, 2014  -  Find a broker to begin trading NBY now
Exchange: AMEX
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

NovaBay Pharmaceuticals Creates Optometry Advisory Board
9/18/2014 7:00:00 AM - Business Wire

NovaBay Pharmaceuticals Will Feature i-Lid Cleanser for the First Time at Vision Expo West
9/16/2014 7:00:00 AM - Business Wire

Hispanic Heroes Honored in Fight Against "Flesh-Eating" Disease
9/15/2014 1:18:00 PM - PR Newswire

Center Director of Omni Eye Surgery in New York City Describes a Promising New Product for the Management of Eyelid Disease in News Publication
9/9/2014 7:00:00 AM - PR Newswire

NovaBay Pharmaceuticals to Present at Rodman & Renshaw 16th Annual Healthcare Conference
9/5/2014 7:00:00 AM - Business Wire

China’s Food and Drug Administration has Cleared NovaBay’s NeutroPhase Skin and Wound Cleanser for Sale throughout Mainland China by NovaBay’s Partner, China Pioneer Pharma
9/3/2014 7:00:00 AM - Business Wire

NovaBay Pharmaceuticals Adds Five Top Ophthalmologists to its Ophthalmic Advisory Board
8/28/2014 7:00:00 AM - Business Wire

NovaBay Pharmaceuticals Deploys Direct Sales Force to Market i-Lid Cleanser Across the U.S.
8/25/2014 7:00:00 AM - Business Wire

Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease'
8/20/2014 12:19:00 PM - PR Newswire

NovaBay Announces Results of NVC-422 Phase 2 for Viral Conjunctivitis
8/20/2014 7:00:00 AM - Business Wire

National Necrotizing Fasciitis Foundation Warns Watch Out For Vibrio Infections
8/12/2014 10:00:00 AM - PR Newswire

NovaBay Pharmaceuticals Reports Second Quarter 2014 Financial Results and a Clinical/Business Update
7/31/2014 8:05:00 AM - Business Wire

NovaBay Pharmaceuticals Announces Direct US Marketing-Sales Campaign for New i-LidTM Cleanser Product
7/16/2014 8:00:00 AM - Business Wire

Letter to NovaBay Shareholders
7/10/2014 6:37:00 PM - Business Wire

NovaBay’s New Product for Serious Eye Conditions Highlighted in CEOLIVE.TV Interview
7/3/2014 8:00:00 AM - Business Wire

British Prime Minister David Cameron Warns of Growing Crisis of Antibiotic-Resistant Bacteria, But Wound Care Expert Dr. John Crew Points to Possible Solution
7/2/2014 4:31:00 PM - PR Newswire

Dr. Christine W. Sindt Will Describe Benefits of NovaBay’s i-Lid Cleanser at American Optometric Association Meeting
6/26/2014 8:00:00 AM - Business Wire